These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9785443)

  • 1. 1-Azaribofuranoside analogues as designed inhibitors of purine nucleoside phosphorylase. Synthesis and biological evaluation.
    Hansen SU; Bols M
    Acta Chem Scand (Cph); 1998 Oct; 52(10):1214-22. PubMed ID: 9785443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
    Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and application of a 96-well enzymatic assay based on LC-ESI-MS/MS quantification for the screening of selective inhibitors against Mycobacterium tuberculosis purine nucleoside phosphorylase.
    Cattaneo G; Ubiali D; Calleri E; Rabuffetti M; Höfner GC; Wanner KT; De Moraes MC; Martinelli LKB; Santos DS; Speranza G; Massolini G
    Anal Chim Acta; 2016 Nov; 943():89-97. PubMed ID: 27769382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases.
    Evans GB; Furneaux RH; Gainsford GJ; Hanson JC; Kicska GA; Sauve AA; Schramm VL; Tyler PC
    J Med Chem; 2003 Jan; 46(1):155-60. PubMed ID: 12502369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of multisubstrate analogue inhibitors of purine nucleoside phosphorylases.
    Yokomatsu T; Hayakawa Y; Kihara T; Koyanagi S; Soeda S; Shimeno H; Shibuya S
    Bioorg Med Chem; 2000 Nov; 8(11):2571-9. PubMed ID: 11092542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel nucleotide analogues possessing a difluoromethylenephosphonato group. Evaluation of the inhibitory activity for purine nucleoside phosphorylase.
    Yokomatsu T; Hayakawa Y; Abe H; Shibuya S; Kihara T; Soeda S; Shimeno H
    Nucleic Acids Symp Ser; 1999; (42):27-8. PubMed ID: 10780362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pyrimidine and purine nucleoside phosphorylases by a 3,5-dichlorobenzoyl-substituted 2-deoxy-D-ribose-1-phosphate derivative.
    Vande Voorde J; Quintiliani M; McGuigan C; Liekens S; Balzarini J
    Biochem Pharmacol; 2012 May; 83(10):1358-63. PubMed ID: 22366108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
    Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
    J Med Chem; 2003 Jul; 46(15):3412-23. PubMed ID: 12852771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
    Beauchamp LM; Tuttle JV; Rodriguez ME; Sznaidman ML
    J Med Chem; 1996 Feb; 39(4):949-56. PubMed ID: 8632418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 5-amino-1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine and certain related nucleosides as inhibitors of purine nucleoside phosphorylase.
    Sanghvi YS; Hanna NB; Larson SB; Fujitaki JM; Willis RC; Smith RA; Robins RK; Revankar GR
    J Med Chem; 1988 Feb; 31(2):330-5. PubMed ID: 3123692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.
    Ealick SE; Babu YS; Bugg CE; Erion MD; Guida WC; Montgomery JA; Secrist JA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11540-4. PubMed ID: 1763067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral acyclic nucleoside phosphonate analogues as inhibitors of purine nucleoside phosphorylase.
    Kulikowska E; Bzowska A; Holy A; Magnowska L; Shugar D
    Adv Exp Med Biol; 1998; 431():747-52. PubMed ID: 9598163
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine.
    Stoeckler JD; Ryden JB; Parks RE; Chu MY; Lim MI; Ren WY; Klein RS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1774-8. PubMed ID: 3081256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of activity of purine nucleoside phosphorylase with N9- and N7-(beta-D-glucofuranuronosyl)purines and 8-substituted N9-(beta-D-ribofuranosyl)purines)].
    Anan'ev AV; Maurin'sh IuA; Paégle RA; Lidak MIu; Akopian ZhI
    Bioorg Khim; 1991 Jun; 17(6):855-6. PubMed ID: 1776970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine nucleoside phosphorylase: inhibition by purine N(7)- and N(9)-acyclonucleosides; and substrate properties of 7-beta-D-ribofuranosylguanine and 7-beta-D-ribofuranosylhypoxanthine.
    Bzowska A; Ananiev AV; Ramzaeva N; Alksins E; Maurins JA; Kulikowska E; Shugar D
    Biochem Pharmacol; 1994 Aug; 48(5):937-47. PubMed ID: 8093106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition state analogue discrimination by related purine nucleoside phosphorylases.
    Taylor Ringia EA; Tyler PC; Evans GB; Furneaux RH; Murkin AS; Schramm VL
    J Am Chem Soc; 2006 Jun; 128(22):7126-7. PubMed ID: 16734442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular rebinding of transition-state analogues provides extended
    Gebre ST; Cameron SA; Li L; Babu YS; Schramm VL
    J Biol Chem; 2017 Sep; 292(38):15907-15915. PubMed ID: 28794158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase.
    Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
    J Med Chem; 2003 Nov; 46(24):5271-6. PubMed ID: 14613329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-[(Phosphonoalkyl)benzyl]guanines. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.
    Kelley JL; Linn JA; McLean EW; Tuttle JV
    J Med Chem; 1993 Oct; 36(22):3455-63. PubMed ID: 8230137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 6-aryloxy- and 6-arylalkoxy-2-chloropurines and their interactions with purine nucleoside phosphorylase from Escherichia coli.
    Bzowska A; Magnowska L; Kazimierczuk Z
    Z Naturforsch C J Biosci; 1999 Dec; 54(12):1055-67. PubMed ID: 10685497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.